FDA Inspection 669116 — Carter BloodCare

Carter BloodCare — FEI 3005680006

The FDA completed an inspection of Carter BloodCare on Jun 17, 2010 in Mansfield, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 17, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mansfield, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.